As of Apr 28
| -0.10 / -0.90%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 23.50, with a high estimate of 39.00 and a low estimate of 17.00. The median estimate represents a +112.48% increase from the last price of 11.06.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.